Literature DB >> 36148082

The rising cost of healthcare and its contribution to the worsening disease burden in developing countries.

Faizan Fazal1, Tayyaba Saleem1, Mohammad Ebad Ur Rehman1, Tehseen Haider1, Abdul Rauf Khalid1, Usama Tanveer1, Haris Mustafa1, Junaid Tanveer1, Arooba Noor1.   

Abstract

Entities:  

Keywords:  Disease burden; Healthcare

Year:  2022        PMID: 36148082      PMCID: PMC9486377          DOI: 10.1016/j.amsu.2022.104683

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
To the Editor, Over the years, the disease burden of communicable and non-communicable diseases among developing countries has been on the rise. Traditionally associated with developed countries, developing countries have seen an unprecedented increase in the past years in non-communicable diseases such as diabetes, cardiovascular diseases, obesity. It was predicted that by 2020, NCD's will be responsible for about 70% of the global burden of disease, causing 7 out of 10 deaths in developing countries [1]. Infectious diseases in parallel are still largely a threat to the developing countries worldwide. Researchers have coined the term ‘Double burden of diseases’ in an attempt to explain the concurrent rise of communicable and non-communicable diseases in developing countries [2]. A review of literature shows that developing countries like Bangladesh, India, Nepal, Pakistan and Sri Lanka spend less that 4% of their GDP on healthcare [3]. This regressive budget allocation has had detrimental effects on the health of these countries. The healthcare system in these countries is underfunded, inefficient and expensive leading to a vicious cycle of increased morbidity and mortality [4]. The rising cost of healthcare is a grave problem for resource depleted countries in addition to the rising burden of diseases. It not only affects the quality of care being provided but also has led to the rationing and limiting of healthcare services [5]. Financial affordability of healthcare is one of the major barriers to healthcare seeking in resource constraint countries [6]. Out of pocket payments for healthcare services are responsible for most of the unmet medical needs in low- and middle-income countries. These payments disproportionately affect people from below the poverty line which leads to further impoverishment and adds to the disease burden [7]. Aside from the cost of healthcare itself, the indirect costs that come with obtaining healthcare such as food, lodging and transportation that discourage people [8]. Another factor that deters poor people is the prohibitive cost and access to essential life saving drugs. This also extends to vaccines for otherwise fatal diseases [9]. This situation calls for an immediate remedial and re-evaluation of our policies regarding healthcare. For developing countries lack of healthcare expenditure, allocation of budget and inadequate resource utilisation is a major problem [10]. Developing countries need to allot a higher proportion of their budget to healthcare as a positive correlation between health outcomes and health financing has been observed [11]. A greater stress on health maintenance and disease prevention is the ideal and efficient approach to counter healthcare budget and cost constraints. There also needs to be a shift of focus towards primary health care, which is a more cost-effective way of delivering health services to a wider population [12]. Globally, healthcare systems with more emphasis on primary care have shown better outcomes especially in countries with high prevalence of non-communicable diseases [13]. Funding of research programs and labs to come up with new diagnostic tests and medications in an attempt to minimize costs can also be done. Training of paramedics, nurses, and pharmacists to play a more active role in healthcare delivery can be fruitful in improving outcomes and prevent negligence [14,15]. Overall, the priority of the developing countries need to be focused around adopting a more humanised approach towards healthcare. Healthcare should be equally accessible to the poor and the rich with no discrimination in the quality of services. A bitter reality is that while the developed world progresses, developing countries health indicators worsen perpetuating the cycle of poverty and illness [16].

Provenance and peer review

Not commissioned, externally peer reviewed.

Sources of funding

None.

Ethical approval

Not applicable.

Consent

Not applicable.

Author contribution

Faizan Fazal: Study conception, write-up, critical review and approval of the final version. Tayyaba saleem: Study conception, write-up, critical review and approval of the final version. Mohammad Ebad Ur Rehman: Study conception, write-up, critical review and approval of the final version. Tehseen Haider: Study conception, critical review and approval of the final version. Abdul rauf khalid: Study conception, write-up, critical review and approval of the final version. Usama Tanveer: Study conception, write-up, critical review and approval of the final version. Haris Mustafa: Study conception, write-up, critical review and approval of the final version. Junaid Tanveer: Study conception, critical review and approval of the final version. Arooba Noor: Study conception, write-up, critical review and approval of the final version.

Registration of research studies

Name of the registry: Not applicable Unique Identifying number or registration ID: Not applicable Hyperlink to your specific registration (must be publicly accessible and will be checked): Not applicable

Guarantor

Faizan Fazal. Mohammad Ebad Ur Rehman.

Declaration of competing interest

The authors have no conflicts of interest.
  10 in total

1.  Estimating the cost of using non-physician providers in primary care teams in an HMO: where would the savings begin?

Authors:  J Hummel; S Pirzada
Journal:  HMO Pract       Date:  1994-12

2.  Health equity: challenges in low income countries.

Authors:  Christopher Garimoi Orach
Journal:  Afr Health Sci       Date:  2009-10       Impact factor: 0.927

Review 3.  The double burden of communicable and non-communicable diseases in developing countries.

Authors:  Abdesslam Boutayeb
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11-04       Impact factor: 2.184

4.  Access to essential drugs in poor countries: a lost battle?

Authors:  B Pécoul; P Chirac; P Trouiller; J Pinel
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

5.  Expanding primary care in South and East Asia.

Authors:  Chris van Weel; Ryuki Kassai
Journal:  BMJ       Date:  2017-02-27

6.  Poverty and access to health care in developing countries.

Authors:  David H Peters; Anu Garg; Gerry Bloom; Damian G Walker; William R Brieger; M Hafizur Rahman
Journal:  Ann N Y Acad Sci       Date:  2007-10-22       Impact factor: 5.691

7.  The global burden of chronic diseases: overcoming impediments to prevention and control.

Authors:  Derek Yach; Corinna Hawkes; C Linn Gould; Karen J Hofman
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

8.  Primary healthcare policy implementation in South Asia.

Authors:  Chris van Weel; Ryuki Kassai; Waris Qidwai; Raman Kumar; Kanu Bala; Pramendra Prasad Gupta; Ruvaiz Haniffa; Neelamani Rajapaksa Hewageegana; Thusara Ranasinghe; Michael Kidd; Amanda Howe
Journal:  BMJ Glob Health       Date:  2016-09-06

9.  Organisation of primary health care systems in low- and middle-income countries: review of evidence on what works and why in the Asia-Pacific region.

Authors:  Rebecca Dodd; Anna Palagyi; Stephen Jan; Marwa Abdel-All; Devaki Nambiar; Pavitra Madhira; Christine Balane; Maoyi Tian; Rohina Joshi; Seye Abimbola; David Peiris
Journal:  BMJ Glob Health       Date:  2019-08-16

10.  Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial.

Authors:  Waris Qidwai; Hasan Bin Hamza; Riaz Qureshi; Anwar Gilani
Journal:  J Altern Complement Med       Date:  2009-06       Impact factor: 2.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.